There is a pioneering quality to Oklahoma City-based Altheus Therapeutics and the milestones the company has achieved in advancing a new drug therapy for a painful condition known as inflammatory bowel disease.

In June 2012, Altheus became the first Oklahoma-based company to launch a Phase 2 trial of a medical drug developed in the Sooner State

The Altheus formulation was conceived by Dr. Richard Harty, a scientist who studied inflammatory bowel disease for more than three decades, including 14 years as chief of gastroenterology and digestive disease at the University of Oklahoma Health Sciences Center.

Read the full story on NewsOK.